FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20250709E00027
1. Date of relevant event: 07/07/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02511
4. Name of listed corporation: 君聖泰醫藥-B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 571,325,668
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) MA
(Other names) Lixiong
10. Name of director (Chinese): 馬立雄 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
 
 		          
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position36,120,7387.02
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position36,120,7386.32
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position30,194,154
2101Beneficial owner
Long position5,926,584
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
01/04/202601/04/2033USD0USD0.328  773,748
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
01/04/202701/04/2033USD0USD0.328  773,748
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
22/12/202501/09/2033USD0USD0.328  600,000
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
22/12/202601/09/2033USD0USD0.328  600,000
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
22/12/202701/09/2033USD0USD0.328  600,000
Long position
4104Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
31/12/202531/12/2031USD0USD0.177  107,898
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
AIH Capital L.P.3-212 Governors Square, 23 Lime Tree Bay Avenue, P.O.Box 30746, Seven Mile Beach,Grand Cayman KY1-1203, Cayman IslandsMa Lixiong100.00N
Long position27,428,154
BAIYI Capital LimitedSea Meadow House, P.O. Box 116, Road Town, Tortola, British Virgin IslandsAIH Capital L.P.100.00Y
Long position27,428,154
Yuthai Investment Management Co., Ltd.Room 201, Building A, No.1, Qianwan 1st Road, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen, Guangdong Province, People's Republic of ChinaMa Lixiong80.00N
Long position2,766,000
Pingtan Rongjing Investment Partnership (Limited Partnership)Room 511, Floor 5, Building 6, Jinjingwan Business Operation Center, Pingtan Comprehensive Experimental Zone, Fuzhou City, Fujian Province, People's Republic of ChinaYuthai Investment Management Co., Ltd.100.00Y
Long position2,766,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: HighTide Therapeutics completed a placing of 56,555,000 new shares as disclosed in the next day disclosure return submitted by the Company on July 7, 2025, resulting in a decrease in the percentage level in the shares of the Company. Box 28: MA was granted options on Dec 31, 2021 and April 1, 2023 under 2020 Share Incentive Plan, September 1, 2023 under 2023 Share Incentive Plan, with 5,926,584 shares in total, 2,471,190 shares have been vested, 3,455,394 shares have not been vested
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 09/07/2025
(dd/mm/yyyy)